About: Clinical Features of Patients with Coronavirus Disease 2019 (COVID‐19) from a Designated Hospital in Beijing, China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical Features of Patients with Coronavirus Disease 2019 (COVID‐19) from a Designated Hospital in Beijing, China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Clinical Features of Patients with Coronavirus Disease 2019 (COVID‐19) from a Designated Hospital in Beijing, China
Creator	Fan, Junfen Hu, Mei Zhou, Qing Bi, Jingfeng An, Yiran Authors, Hospital Fan, Huahao Gu, Fengjun Lijun, : Shen, Lijun
source	Medline; PMC
abstract	Clinical and laboratory data available on patients with coronavirus disease 2019 (COVID‐19) in Beijing, China remain extremely limited. Here, we summarized the clinical characteristics of patients with COVID‐19 in a designated hospital in Beijing, China. 55 patients with laboratory‐confirmed SARS‐CoV‐2 infection were admitted to Beijing 302 Hospital and enrolled in this study. Demographic data, symptoms, comorbidities, laboratory values, treatments, and clinical outcomes were all collected and retrospectively analyzed. 15 (27.3%) of the patients had non‐severe symptom, the mean age was 44.0 years (interquartile range 34.0‐56.0), and median incubation period was 7.5 days (interquartile range 5.0‐11.8). 26 (47.3%) patients had exposure history in Wuhan while 20 (36.4%) were associated with familial clusters. 18 (32.7%) had underlying comorbidities including hypertension. The most common symptoms of illness were fever (45, 81.8%), 51 (92.7%) patients had abnormal findings on chest CT. Laboratory findings showed that neutrophil count, percentage of lymphocyte, percentage of eosinophil, eosinophil count, erythrocyte sedimentation rate, albumin, and serum ferritin are potential risk factors for patients with poor prognosis. 26 patients (47.3%) were still hospitalized while 29 (52.7%) had been discharged at this point. Compared with patients in Wuhan, the symptoms of patients in Beijing are relatively mild. Older age, more comorbidities, and more abnormal prominent laboratory markers were associated with severe condition. On the basis of antiviral drugs, antibiotics treatment, appropriate dosage of corticosteroid and gamma globulin therapy significantly improve patients’ outcomes. Early identification and timely medical treatment are important to reduce the severity of patients with COVID‐19. This article is protected by copyright. All rights reserved.
has issue date	2020-05-05(xsd:dateTime)
bibo:doi	10.1002/jmv.25966
bibo:pmid	32369208
has license	no-cc
sha1sum (hex)	13c23e37aa9c588e22ca4c388fcaae05c8d9503a
schema:url	https://doi.org/10.1002/jmv.25966
resource representing a document's title	Clinical Features of Patients with Coronavirus Disease 2019 (COVID‐19) from a Designated Hospital in Beijing, China
has PubMed Central identifier	PMC7267635
has PubMed identifier	32369208
schema:publication	J Med Virol
resource representing a document's body	covid:13c23e37aa9c588e22ca4c388fcaae05c8d9503a#body_text
is schema:about of	named entity 'Older' named entity 'antiviral drugs' named entity 'SARS-CoV-2' named entity 'patients' named entity 'patients' named entity 'symptoms' named entity 'laboratory' named entity 'patients' named entity 'symptoms' named entity 'ferritin' named entity 'coronavirus disease 2019' named entity 'risk factors' named entity 'Features' named entity 'Coronavirus' named entity 'EOSINOPHIL' named entity 'CONDITION' named entity 'DESIGNATED' named entity 'EOSINOPHIL COUNT' named entity 'ARTICLE' named entity 'OLDER AGE' named entity 'TO REDUCE' named entity 'NEUTROPHIL COUNT' named entity 'HERE' named entity 'SEVERITY' named entity 'SIGNIFICANT' named entity 'COVID-19' named entity 'MEDIAN' named entity 'CLUSTERS' named entity 'PROGNOSIS' named entity 'CORONAVIRUS DISEASE 2019' named entity 'BEIJING' covid:arg/13c23e37aa9c588e22ca4c388fcaae05c8d9503a named entity 'erythrocyte sedimentation rate' named entity 'mild' named entity 'patients' named entity 'reduce' named entity 'count' named entity 'gamma globulin' named entity 'interquartile range' named entity 'Wuhan' named entity 'severe' named entity 'extremely' named entity 'collected' named entity 'patients' named entity 'age' named entity 'Abstract' named entity 'prognosis' named entity 'eosinophil' named entity 'gamma globulin' named entity 'chest CT' named entity '5.0' named entity 'comorbidities' named entity 'corticosteroid' named entity 'hypertension' named entity 'clinical outcomes' named entity 'China' named entity 'eosinophil' named entity 'interquartile range' named entity 'Wuhan' named entity 'clinical characteristics' named entity 'COVID-19' named entity 'Clinical Features' named entity 'COVID' named entity 'serum ferritin' named entity 'eosinophil' named entity 'lung' named entity 'interferon alpha' named entity 'Chinese medicine' named entity 'clinical laboratory' named entity 'comorbidities' named entity 'liver function' named entity 'lung inflammation'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software